References
Alvarez R, González P, Batalla A, Reguero JR, Iglesias-Cubero G, Hevia S, Cortina A, Merino E, González I, Alvarez V, Coto E (2001) Association between the NOS3 (−786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 5:343–348
Aras O, Hanson NQ, Bakanay SM, Tsai MY, Gulec S (2002) Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population. Thromb Haemost 87:347–349
Bor-Kucukatay M, Demir S, Akbay R, Dursunoglu D, Akdag B, Semiz E (2010) Relationship between hemorheology and Glu(298)Asp polymorphism of endothelial nitric oxide synthase gene in patients with coronary artery disease. Mol Biol Rep 37:171–178
Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F (1992) Deletion polymorphisms in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641–644
Casas JP, Bautista LE, Humphries SE, Hingorani AD (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease. Meta-analysis of 26 studies involving 23,028 subjects. Circulation 109:1359–1365
Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, Biagini A, Clerico A (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49:389–395
Dubey RK, Jackson EK, Luscher TF (1995) Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic-nucleotides and angiotensin 1 receptors. J Clin Invest 96:141–149
Dzimiri N, Basco C, Moorji A, Meyer BF (2000) Angiotensin-converting enzyme polymorphism and the risk of coronary heart disease in the Saudi male population. Arch Pathol Lab Med 124:531–534
El Moncer W, Esteban E, Bahri R, Gayà-Vidal M, Carreras-Torres R, Athanasiadis G, Moral P, Chaabani H (2010) Mixed origin of the current Tunisian population from the analysis of Alu and Alu/STR compound systems. J Hum Genet 55:827–833
Erdös EG (1990) Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 16:363–370
Fatini C, Sofi F, Sticchi E, Gensini F, Gori AM, Fedi S, Lapini I, Rostagno C, Comeglio M, Brogi D, Gensini G, Abbate R (2004) Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 147:516–521
Ghilardi G, Biondi ML, De Monti M, Bernini M, Turri O, Massaro F, Guagnellini E, Scorza R (2002) Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene. Clin Chem 48:989–993
Guldiken B, Sipahi T, Guldiken S, Ustundag S, Budak M, Turgut N, Ozkan H (2009) Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke. Mol Biol Rep 36:1539–1543
Hamelin BA, Zakrzewski-Jakubiak M, Robitaille NM, Bogaty P, Labbé L, Turgeon J (2011) Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene polymorphism is age dependent. J Clin Pharmacol 51:1286–1292
Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O’Shaughnessy KM, Brown MJ (1999) A common variant of the endothelial nitric oxide synthase (Glu298 → Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515–1520
Keavney B, McKenzie CA, Connell JMC, Julier C, Ratcliffe PJ, Sobel E, Lathrop M, Farrall M (1998) Measured haplotype analysis of the angiotensin-I-converting enzyme gene. Hum Mol Genet 7:1745–1751
Kim IJ, Bae J, Lim SW, Cha DH, Cho HJ, Kim S, Yang DH, Hwang SG, Oh D, Kim NK (2007) Influence of endothelial nitric oxide synthase gene polymorphisms 8(−786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Thromb Res 119:579–585
Kincl V, Vasků A, Meluzín J, Panovský R, Seménka J, Groch L (2009) Association of the eNOS 4a/b and −786T/C polymorphisms with coronary artery disease, obesity and diabetes mellitus. Folia Biol (Praha) 55:187–191
Lacchini R, Silva PS, Tanus-Santos JE (2010) A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol 106:357–361
Maalej A, Rebai A, Ayadi A, Jouida J, Makni H, Ayadi H (2004) Allelic structure and distribution of 103 STR loci in a Southern Tunisian population. J Genet 83:65–71
Marcadet A, O’Connel P, Cohen D (1987) Standardized southern blot workshop techniques. In: Dupont B (ed) Histocompatibility testing. Springer, New York, pp 587–590
Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, Rios-Santos F, Tanus-Santos JE (2005) Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12:177–182
Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, Tanus-Santos JE (2005) Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15:565–570
Metzger IF, Sertório JT, Tanus-Santos JE (2007) Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43:987–992
Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE (2011) Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Pharmacogenomics J 11:393–399
Nagassaki S, Sertório JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE (2006) eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 41:1044–1049
Nagassaki S, Herculano RD, Graeff CF, Tanus-Santos JE (2009) eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. Eur J Clin Pharmacol 65:385–392
Nakagami H, Ikeda U, Maeda Y, Yamamoto K, Hojo Y, Kario K, Kuroki S, Shimada K (1999) Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms. J Thromb Thrombolysis 8:191–195
Nakayama T, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K (1999) T-786C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864–2870
Rebai M, Kharrat N, Ayadi I, Rebai A (2006) Haplotype structure of five SNPs within the ACE gene in the Tunisian population. Ann Hum Biol 33:319–329
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346
Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2007) Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16:348–355
Sediri Y, Kallel A, Ayadi I, Feki M, Elasmi M, Haj Taieb S, Sanhaji H, Souheil O, Jemaa R, Kaabachi N (2010) Lack of association between endothelial nitric oxide synthase gene G894T polymorphism and hypertension in the Tunisian population. Prev Med 51:88–89
Shanmugan V, Sell KW, Saha BK (1993) Mistyping ACE heterozygotes. PCR Methods Appl 3:120–121
Souza-Costa DC, Sandrim VC, Lopes LF, Gerlach RF, Rego EM, Tanus-Santos JE (2007) Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis 193:438–444
Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989
Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, Smits P (2002) The Glu298Asp polymorphisms of the NOS3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20:2023–2027
Vogel F, Motulsky AG (1997) Human genetics: problems and approaches, 3rd edn. Springer, Heidelberg
Weir BS (1996) Genetic data analysis, 2nd edn. Sinauer Associates, Sunderland
Wilson PWF, Culletton BF (1998) Epidemiology of cardiovascular disease in the United States. Am J Kidney Dis 32:56–65
Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103:65–69
Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Miyamoto Y, Ogawa Y, Kaneshige T, Hiramatsu H, Yoshioka T, Kamitani S, Teraoka H, Nakao K (2000) Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786C and missense Glu298Asp variants. J Invest Med 48:367–374
Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R (2001) Linkage and association analysis of angiotensin I-converting enzyme (ACE) gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 68:1139–1148
Zintzaras E, Raman G, Kitsios G, Lau J (2008) Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 168:1077–1089
Acknowledgments
This work was supported by the Ministry of Higher Education and Scientific Research, Tunisia. We would like to thank Mr. Nouri of the Cardiology Service of the Chedi Chaker Hospital for his technical assistance. We express also our gratitude to Prof. J. Jaoua, founder and former Head of the English Department at Sfax Faculty of Sciences, for proofreading the manuscript. We also would like to thank M. Choura for her help in improving the manuscript and her friendliness.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdelhedi, R., Kharrat, N., Bouayed, N.A. et al. Lack of Association of NOS3 and ACE Gene Polymorphisms with Coronary Artery Disease in Southern Tunisia. Biochem Genet 51, 92–100 (2013). https://doi.org/10.1007/s10528-012-9545-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-012-9545-x